231 related articles for article (PubMed ID: 36241658)
1. KIR-HLA gene diversities and susceptibility to lung cancer.
Hematian Larki M; Ashouri E; Barani S; Ghayumi SMA; Ghaderi A; Rajalingam R
Sci Rep; 2022 Oct; 12(1):17237. PubMed ID: 36241658
[TBL] [Abstract][Full Text] [Related]
2. The impact of killer cell immunoglobulin-like receptor (KIR) genes and human leukocyte antigen (HLA) class I ligands on predisposition or protection against prostate cancer.
Roshan Zamir M; Ariafar A; Ghaderi A; Amirzargar A
Immunobiology; 2023 Mar; 228(2):152319. PubMed ID: 36599262
[TBL] [Abstract][Full Text] [Related]
3. Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.
Tajik N; Shahsavar F; Nasiri M; Radjabzadeh MF
Int J Immunogenet; 2010 Jun; 37(3):159-68. PubMed ID: 20193031
[TBL] [Abstract][Full Text] [Related]
4. Genetic profiles of killer-cell immunoglobulin-like receptors and HLA ligands in Thai blood donors.
Kitpoka P; Tammakorn C; Chaisri S; Leelayuwat C; Mongkolsuk T; Thammanichanond D
Hum Immunol; 2016 Jun; 77(6):470-5. PubMed ID: 27131859
[TBL] [Abstract][Full Text] [Related]
5. Association of killer cell immunoglobulin-like receptors and their cognate HLA class I ligands with susceptibility to acute myeloid leukemia in Iranian patients.
Mirzazadeh S; Bemani P; Halimi H; Sanaee MN; Karami N; Ramzi M; Farjadian S
Sci Rep; 2023 Jul; 13(1):11456. PubMed ID: 37454198
[TBL] [Abstract][Full Text] [Related]
6. Killer-cell immunoglobulin-like receptor (KIR) and human leukocyte antigen (HLA) class I genetic diversity in four South African populations.
Gentle NL; Loubser S; Paximadis M; Puren A; Tiemessen CT
Hum Immunol; 2017; 78(7-8):503-509. PubMed ID: 28571758
[TBL] [Abstract][Full Text] [Related]
7. Genetic associations of killer immunoglobulin like receptors and class I human leukocyte antigens on childhood acute lymphoblastic leukemia among north Indians.
Misra MK; Prakash S; Moulik NR; Kumar A; Agrawal S
Hum Immunol; 2016 Jan; 77(1):41-46. PubMed ID: 26472014
[TBL] [Abstract][Full Text] [Related]
8. HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute ischemic stroke.
Tuttolomondo A; Di Raimondo D; Pecoraro R; Casuccio A; Di Bona D; Aiello A; Accardi G; Arnao V; Clemente G; Corte VD; Maida C; Simonetta I; Caruso C; Squatrito R; Pinto A;
J Neuroinflammation; 2019 Apr; 16(1):88. PubMed ID: 30995924
[TBL] [Abstract][Full Text] [Related]
9. Understanding the killer-cell immunoglobulin like receptor polymorphism in retinoblastoma.
Aggarwal R; Sharma M; Singh U; Poulton K; Bhatia T; Mangat N; Kakkar N; Bansal D
Ophthalmic Genet; 2023 Feb; 44(1):1-5. PubMed ID: 36594723
[TBL] [Abstract][Full Text] [Related]
10. Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.
Shastry A; Sedimbi SK; Rajalingam R; Nikitina-Zake L; Rumba I; Wigzell H; Sanjeevi CB
Int J Immunogenet; 2008 Dec; 35(6):439-46. PubMed ID: 19046302
[TBL] [Abstract][Full Text] [Related]
11. The investigation of killer-cell immunoglobulin-like receptors (KIRs) and their HLA ligands in Iranian patients with myasthenia gravis.
Jalalvand M; Beigmohammadi F; Soltani S; Ehsan S; Rajabkhah S; Madreseh E; Akhtari M; Jamshidi A; Farhadi E; Mahmoudi M; Nafissi S
Clin Neurol Neurosurg; 2024 Mar; 238():108171. PubMed ID: 38422742
[TBL] [Abstract][Full Text] [Related]
12. The Relationship Between Killer Cell Immunoglobulin-Like Receptors and HLA-C Polymorphisms in Colorectal Cancer in a Saudi Population.
Al Omar SY; Mansour L; Dar JA; Alwasel S; Alkhuriji A; Arafah M; Al Obeed O; Christmas S
Genet Test Mol Biomarkers; 2015 Nov; 19(11):617-22. PubMed ID: 26383988
[TBL] [Abstract][Full Text] [Related]
13. Association of Killer Cell Immunoglobulin-Like Receptors and Their HLA-Ligands with Type 1 Diabetes Among South Indian Population.
Gunavathy N; Asirvatham A; Chitra A; Jayalakshmi M
Immunol Invest; 2023 Apr; 52(3):270-285. PubMed ID: 36705596
[TBL] [Abstract][Full Text] [Related]
14. Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study.
Varbanova VP; Mihailova S; Naumova E; Mihaylova AP
Turk J Haematol; 2019 Nov; 36(4):238-246. PubMed ID: 31337191
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility to pulmonary tuberculosis in Iranian individuals is not affected by compound KIR/HLA genotype.
Tajik N; Shah-hosseini A; Mohammadi A; Jafari M; Nasiri M; Radjabzadeh MF; Farnia P; Jalali A
Tissue Antigens; 2012 Feb; 79(2):90-6. PubMed ID: 22128749
[TBL] [Abstract][Full Text] [Related]
16. KIR and HLA Genotypes Implicated in Reduced Killer Lymphocytes Immunity Are Associated with Vogt-Koyanagi-Harada Disease.
Levinson RD; Yung M; Meguro A; Ashouri E; Yu F; Mizuki N; Ohno S; Rajalingam R
PLoS One; 2016; 11(8):e0160392. PubMed ID: 27490240
[TBL] [Abstract][Full Text] [Related]
17. Increased frequencies of the killer immunoglobulin-like receptor genes KIR2DL2 and KIR2DS2 are associated with neuroblastoma.
Keating SE; Ní Chorcora C; Dring MM; Stallings RL; O'Meara A; Gardiner CM
Tissue Antigens; 2015 Sep; 86(3):172-7. PubMed ID: 26202659
[TBL] [Abstract][Full Text] [Related]
18. KIR2DS3 is associated with protection against acute myeloid leukemia.
Shahsavar F; Tajik N; Entezami KZ; Fallah Radjabzadeh M; Asadifar B; Alimoghaddam K; Ostadali Dahaghi M; Jalali A; Ghashghaie A; Ghavamzadeh A
Iran J Immunol; 2010 Mar; 7(1):8-17. PubMed ID: 20371915
[TBL] [Abstract][Full Text] [Related]
19. Imbalance of Genes Encoding Natural Killer Immunoglobulin-Like Receptors and Human Leukocyte Antigen in Patients With Biliary Cancer.
Cornillet M; Jansson H; Schaffer M; Hertwig L; Berglin L; Zimmer CL; Johansson H; Ellis E; Isaksson B; Gonzalez-Galarza FF; Middleton D; Malmberg KJ; Sparrelid E; Björkström NK
Gastroenterology; 2019 Oct; 157(4):1067-1080.e9. PubMed ID: 31229495
[TBL] [Abstract][Full Text] [Related]
20. Diversity and association of HLA/KIR receptors with type 2 diabetes in South India.
Chinniah R; Vijayan M; Sivanadham R; Ravi P; Panneerselvam D; Kannan A; Karuppiah B
Int J Immunogenet; 2019 Jun; 46(3):166-178. PubMed ID: 30809938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]